BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
oxygenta pharmaceutical limite stock

OXYGENTA PHARMACEUTICAL LIMITE Share Price

92 0.00 (0.00%)
Dec 12 2024 12:00 AM Pharmaceuticals NSE: OXYGENTAPH

OXYGENTA PHARMACEUTICAL LIMITE Share Price Update

As of the latest trading session, OXYGENTA PHARMACEUTICAL LIMITE share price is currently at 92, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 91.50 and 92.67. Over the past year, OXYGENTA PHARMACEUTICAL LIMITE has achieved a return of 176.59 %. In the last month alone, the return has been 4.35 %. Read More...

OXYGENTA PHARMACEUTICAL LIMITE Performance

Day Range

Low91.50 High92.67
92.00

52 Week Range

Low 26.01 High 108.64
92.00

OXYGENTA PHARMACEUTICAL LIMITE Share Price

524636

OXYGENTAPH

img img img img
No Data Available

Open Price

91.50

Prev. Close

92.00

Volume (Shares)

18255.00

Total traded value

16.77

Upper Circuit

93.84

Lower Circuit

90.16

Note: The current prices & values are delayed, Login to your account for live updates.

OXYGENTA PHARMACEUTICAL LIMITE Fundamentals


(Standalone)

Market Cap (Cr) 326.40
PE Ratio (TTM) 9200.00
Book Value / Share -5.95
Beta 0.33
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -2.85

OXYGENTA PHARMACEUTICAL LIMITE Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 14.01
Operating Expense 17.53
Net Profit -2.85
Net Profit Margin (%) -20.34
Earnings Per Share (EPS) -0.81
EBITDA -1.42
Effective Tax Rate (%) -2.88
Particulars JUN 2024 (Values in Cr)
Revenue 12.62
Operating Expense 15.46
Net Profit -1.36
Net Profit Margin (%) -10.77
Earnings Per Share (EPS) -0.39
EBITDA -1.75
Effective Tax Rate (%) 51.41
Particulars MAR 2024 (Values in Cr)
Revenue 10.55
Operating Expense 13.39
Net Profit 8.02
Net Profit Margin (%) 76.01
Earnings Per Share (EPS) 2.55
EBITDA -1.35
Effective Tax Rate (%) 409.26
Particulars DEC 2023 (Values in Cr)
Revenue 9.15
Operating Expense 12.67
Net Profit -3.78
Net Profit Margin (%) -41.31
Earnings Per Share (EPS) -0.99
EBITDA -2.50
Effective Tax Rate (%) -6.47
Particulars SEP 2023 (Values in Cr)
Revenue 13.08
Operating Expense 16.23
Net Profit -3.16
Net Profit Margin (%) -24.15
Earnings Per Share (EPS) -0.87
EBITDA -2.01
Effective Tax Rate (%) 0.62
Particulars MAR 2024 (Values in Cr)
Revenue 39.64
Operating Expense 53.59
Net Profit -3.48
Net Profit Margin (%) -8.77
Earnings Per Share (EPS) -1.09
EBITDA -9.62
Effective Tax Rate (%) 74.90
Particulars MAR 2023 (Values in Cr)
Revenue 30.99
Operating Expense 41.65
Net Profit -11.57
Net Profit Margin (%) -37.33
Earnings Per Share (EPS) -6.36
EBITDA -7.82
Effective Tax Rate (%) -1.75
Particulars MAR 2022 (Values in Cr)
Revenue 60.52
Operating Expense 61.56
Net Profit -0.61
Net Profit Margin (%) -1.00
Earnings Per Share (EPS) -0.48
EBITDA 2.02
Effective Tax Rate (%) -24.48
Particulars MAR 2021 (Values in Cr)
Revenue 52.03
Operating Expense 51.18
Net Profit 2.93
Net Profit Margin (%) 5.63
Earnings Per Share (EPS) 2.87
EBITDA 6.11
Effective Tax Rate (%) 6.38
Particulars MAR 2020 (Values in Cr)
Revenue 13.72
Operating Expense 23.66
Net Profit -5.79
Net Profit Margin (%) -42.20
Earnings Per Share (EPS) -5.67
EBITDA -3.85
Effective Tax Rate (%) 2.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share -6.18
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -24.27
Particulars MAR 2023 (Values in Cr)
Book Value / Share -32.53
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -25.27
Particulars MAR 2022 (Values in Cr)
Book Value / Share -24.38
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 2.43
Particulars MAR 2021 (Values in Cr)
Book Value / Share -37.27
ROE % -5.79
ROCE % 7.89
Total Debt to Total Equity 0.00
EBITDA Margin 7.55
Particulars MAR 2020 (Values in Cr)
Book Value / Share -40.14
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -57.14
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 63.19
Total Liabilities 63.19
Total Equity -20.12
Share Outstanding 33483500
Price to Book Ratio -4.69
Return on Assets (%) -5.50
Return on Capital (%) -9.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 54.26
Total Liabilities 54.26
Total Equity -46.20
Share Outstanding 14201300
Price to Book Ratio -1.13
Return on Assets (%) -21.32
Return on Capital (%) -53.09
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 31.17
Total Liabilities 31.17
Total Equity -34.62
Share Outstanding 14201300
Price to Book Ratio -0.99
Return on Assets (%) -1.95
Return on Capital (%) -3.49
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 33.86
Total Liabilities 33.86
Total Equity -38.01
Share Outstanding 10201300
Price to Book Ratio 0.00
Return on Assets (%) 8.65
Return on Capital (%) 29.69
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 18.62
Total Liabilities 18.62
Total Equity -40.94
Share Outstanding 10201300
Price to Book Ratio 0.00
Return on Assets (%) -31.08
Return on Capital (%) 38.56
Particulars MAR 2024 (Values in Cr)
Net Income -13.87
Cash from Operations -13.04
Cash from Investing -4.08
Cash from Financing 17.13
Net change in Cash 0.00
Free Cash Flow -8.94
Particulars MAR 2023 (Values in Cr)
Net Income -11.37
Cash from Operations -1.63
Cash from Investing -9.63
Cash from Financing 11.22
Net change in Cash -0.04
Free Cash Flow 8.01
Particulars MAR 2022 (Values in Cr)
Net Income -0.48
Cash from Operations -1.55
Cash from Investing -4.94
Cash from Financing 6.33
Net change in Cash -0.28
Free Cash Flow 3.38
Particulars MAR 2021 (Values in Cr)
Net Income 3.14
Cash from Operations -1.40
Cash from Investing -6.71
Cash from Financing 8.66
Net change in Cash 0.32
Free Cash Flow 5.33
Particulars MAR 2020 (Values in Cr)
Net Income -5.94
Cash from Operations -2.74
Cash from Investing -0.49
Cash from Financing 3.18
Net change in Cash 0.09
Free Cash Flow -2.22
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 37.45 3.55 499.34 37.54 / 77.70
BLISS GVS PHARMA LTD 151.80 19.00 1.58 1598.94 92.25 / 172.40
CIPLA LTD 1454.20 25.44 4.14 117443.01 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 410.00 142.36 4.15 1206.67 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2345.45 49.56 23.75 39733.34 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 56.66 11.07 499.34 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.55 45.59 7.27 2167.00 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6595.05 128.08 24.26 16487.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 151.80 19.79 1.56 1598.94 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 92.50
  • 26 Days 87.40
  • 10 Days 88.40
  • 50 Days 83.30
  • 12 Days 87.40
  • 100 Days 69.20
  • 20 Days 86.10
  • 200 Days 35.20
90.86
PIVOT
First Resistance 90.86
Second Resistance 90.86
Third Resistance 90.86
First Support 90.86
Second Support 90.86
Third Support 90.86
RSI 57.94
MACD 0.00
Commodity Channel Index (CCI) 76.65
ADX 42.40
Williams % R -24.40

Over 1 Month

down

4.35

Over 3 Months

down

93.48

Over 6 Months

down

160.79

Over 1 Year

down

176.59

Over 3 Years

down

48.13

Over 5 Years

down

0.00

OXYGENTA PHARMACEUTICAL LIMITE Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

OXYGENTA PHARMACEUTICAL LIMITE Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
46.69
Promoter Holdings
53.28
FII
0.0
DII
0.02
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
M V S Prasad Reddy Shareholding of Promoter and Promoter Group 9452902.0 26.64
Sravani Reddy Gantla Public Shareholding 4487000.0 12.65
Sunil Vishram Chawda Shareholding of Promoter and Promoter Group 4161200.0 11.73
Sandeep Kumar Reddy Kommidi Public Shareholding 2756500.0 7.77
Aakanksha M Chawda Shareholding of Promoter and Promoter Group 1582500.0 4.46
Manoj Sunil Chawda Shareholding of Promoter and Promoter Group 1582500.0 4.46
Subba Reddy Bhimavarapu Public Shareholding 1532800.0 4.32
Snigdha Vankineni Shareholding of Promoter and Promoter Group 1143000.0 3.22
Kumuda Katasani Public Shareholding 889300.0 2.51
Sanagari Kondal Reddy Public Shareholding 500000.0 1.41
B Subba Reddy Public Shareholding 467400.0 1.32
Sumanth Simha Vankineni Shareholding of Promoter and Promoter Group 343700.0 0.97
Sai Sudhakar Vankineni Shareholding of Promoter and Promoter Group 230000.0 0.65
Amigos Molecular Solutions Private Limited Shareholding of Promoter and Promoter Group 200000.0 0.56
Rachamallu Aparna Shareholding of Promoter and Promoter Group 100000.0 0.28
Sadasiva Reddy Devagudi Shareholding of Promoter and Promoter Group 84400.0 0.24
Jhansi Rani Vankineni Shareholding of Promoter and Promoter Group 26000.0 0.07
K. Raghavender Rao Shareholding of Promoter and Promoter Group 0.0 0.0

OXYGENTA PHARMACEUTICAL LIMITE

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About OXYGENTA PHARMACEUTICAL LIMITE

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by OXYGENTA PHARMACEUTICAL LIMITE

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Oxygenta Pharmaceutical Ltd?

Answer Field

The share price of Oxygenta Pharmaceutical Ltd for NSE is ₹ 0.00 and for BSE is ₹ 92.00.

What is the Market Cap of Oxygenta Pharmaceutical Ltd?

Answer Field

The market cap of Oxygenta Pharmaceutical Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 3,26.40 Cr. as of now.

What is the 52 Week High and Low of Oxygenta Pharmaceutical Ltd?

Answer Field

The 52 Week High and Low of Oxygenta Pharmaceutical Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 108.64 and ₹ 26.01.

How to Buy Oxygenta Pharmaceutical Ltd share?

Answer Field

You can trade in Oxygenta Pharmaceutical Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Oxygenta Pharmaceutical Ltd?

Answer Field

The 1 year returns on the stock has been 176.59%.

What is the Current Share Price of Oxygenta Pharmaceutical Ltd?

Answer Field

Oxygenta Pharmaceutical Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 92.00 as on Dec 12 2024 12:00 AM.

What is the Market Cap of Oxygenta Pharmaceutical Ltd Share?

Answer Field

The market cap of Oxygenta Pharmaceutical Ltd for NSE ₹ 0.0 & for BSE ₹ 3,26.40 as on Dec 12 2024 12:00 AM.

What is the P/E Ratio of Oxygenta Pharmaceutical Ltd Share?

Answer Field

As on Dec 12 2024 12:00 AM the price-to-earnings (PE) ratio for Oxygenta Pharmaceutical Ltd share is 9200.00.

What is the PB ratio of Oxygenta Pharmaceutical Ltd Share?

Answer Field

As on Dec 12 2024 12:00 AM, the price-to-book (PB) ratio for Oxygenta Pharmaceutical Ltd share is -5.95.

How to Buy Oxygenta Pharmaceutical Ltd Share?

Answer Field

You can trade in Oxygenta Pharmaceutical Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Oxygenta Pharmaceutical Ltd Share on Bajaj Broking App?

Answer Field

To buy Oxygenta Pharmaceutical Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Oxygenta Pharmaceutical Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader